くすりのしおり

Injection
Revised: 5/2017

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
Xolair for s.c. injection 75mg
 Active ingredient:
Omalizumab
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine suppresses IgE in the body which is responsible for bronchial asthma and relieves airway inflammation to prevent asthma attack. It is not intended to control an asthmatic attack which has already developed. It also relieves symptoms of chronic idiopathic urticaria.
It is usually used to treat refractory bronchial asthma whose symptoms are not able to be controlled with conventional therapy and to treat refractory chronic spontaneous/idiopathic urticaria (CSU/CIU) which the effect of conventional therapy is insufficient.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • Bronchial asthma: In general, inject subcutaneously once every 2 or 4 weeks, according to your blood IgE level and body weight.
  • Chronic spontaneous/idiopathic urticaria: In general, inject 300 mg at a time subcutaneously every 4 weeks.In any case, depending on your response to the treatment, this medicine may be administered over a long period of time.
  • Depending on your response to the treatment, this medicine may be administered over a long period of time.

Precautions while taking this medicine

  • The medicine may cause dizziness, fatigue, syncope or drowsiness. Pay close attention when you drive a car or operate dangerous machinery.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include hives, dullness, headache, nasopharyngitis and erythema/swelling/itch/pain/heat sensation/induration/bleeding in injection site. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • breathing difficulty, decreased consciousness, swelling of tongue/lips/throat [shock, anaphylaxis]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z